Iruxol ointment 30 g, tube

Description

Iruxol ointment 30 g, tube.

Composition

Each gram of Iruxol ointment contains 10,000 units of collagenase and 100,000 units of chloramphenicol as active ingredients. The ointment also includes several excipients such as petrolatum, sorbitan sesquioleate, and lanolin alcohols.

Therapeutic indications

Iruxol ointment is a medication used for the treatment of chronic dermal ulcers and severely burned areas. The enzymatic activity of collagenase in Iruxol ointment helps to remove necrotic tissue by breaking down collagen, which is a major component of necrotic tissue. This process promotes the healing of the wound.

Contraindications

Iruxol ointment is contraindicated in patients who have a history of hypersensitivity to collagenase, chloramphenicol, or any other components of the formulation. It is also not recommended for use in patients with a systemic infection or a local infection at the site of application.

Special warnings and precautions for use

Due to the presence of chloramphenicol in Iruxol ointment, which can cause serious side effects like aplastic anemia and other blood dyscrasias, it should be used with caution and under the supervision of a healthcare professional. The ointment is for external use only and should be kept out of reach of children. Avoid contact with eyes, mucous membranes and healthy skin surrounding the wound.

Interactions with other medicinal products and other forms of interaction

Iruxol ointment can interact with certain medications or substances, which can affect how it works. For instance, the ointment can react with metal ions in silver-containing products, which can inhibit the activity of collagenase. Therefore, use of Iruxol ointment with silver-containing products should be avoided.

Pregnancy and lactation

There is not enough data on the use of Iruxol ointment during pregnancy and lactation. Therefore, it should only be used during pregnancy or lactation if the potential benefits justify the potential risks to the fetus or infant. Seek advice from your healthcare professional before using this medication.

Effects on ability to drive and use machines

Iruxol ointment has no or negligible influence on the ability to drive or use machines.

Undesirable effects

Some patients may experience side effects when using Iruxol ointment. The most common side effect is local irritation at the site of application, which can result in redness, swelling, pain, and itching. In rare cases, systemic allergic reactions may occur. If you observe any side effects, discontinue use and consult your healthcare professional.

Overdose

In case of accidental ingestion of Iruxol ointment, seek immediate medical attention. Although an overdose of this medication is unlikely to cause life-threatening symptoms, it can cause stomach upset or discomfort.

Pharmacological properties

Iruxol ointment is a topical enzymatic debriding agent that works by breaking down collagen in necrotic tissue, which aids in wound healing. The ointment also contains chloramphenicol, an antibiotic that helps prevent or treat bacterial infections at the wound site.

Pharmaceutical particulars

Iruxol ointment is a yellowish, soft ointment with a characteristic odor. It is packaged in a 30 g aluminum tube and should be stored at room temperature, away from heat and light.

Instructions for use and handling

Before applying Iruxol ointment, clean the wound area and remove as much loose necrotic tissue as possible. Apply a thin layer of the ointment to the wound area once or twice daily, or as directed by your healthcare professional. Always wash your hands before and after applying this medication. If the condition does not improve or worsens after regular use, consult your healthcare professional.